Get the app
US › Healthcare

Heart Test Laboratories Inc. Common Stock (HSCS)

US · Healthcare · Medical Devices

$3.02-5.03%
Last close · 2026-10-16

Latest quarter · ended 2026-07-31

Revenue
$2,100
Revenue YoY
+10.5%
Net profit
$-3.2M
EPS
$-0.86
EPS estimate
$-0.78
Net margin
-151,064.0%

EPS came in at -0.86 against a street estimate of -0.78 — a miss of 10.3%.

Key statistics

Market cap
$14.5M
Forward P/E
0.0
P/B
70.85
Book value
$-0.52
EPS (TTM)
$-3.15
52-week high
$5.25
52-week low
$1.63
50-day MA
$3.34
200-day MA
$2.71
Beta
1.77

Analyst view

Analysts rate Heart Test Laboratories Inc. Common Stock a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $12.00.

Shareholding

Insiders
15.65%
Institutions
3.20%

Largest institutional holders

FundStake
TFB Advisors LLC0.61%
Geode Capital Management, LLC0.48%
Vanguard Capital Management, LLC0.37%
Vanguard Fiduciary Trust Co0.36%
Tradition Wealth Management LLC0.35%
Citadel Advisors Llc0.30%
Citigroup Inc0.12%
UBS Group AG0.12%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Heart Test Laboratories Inc. Common Stock — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-18.